Key Points Residual ATG exposure delays CD4+ T-cell reconstitution more severely after CBT than after BMT. Filgrastim (G-CSF), given early after CBT, enhances ATG-mediated T-cell clearance in patients with residual ATG exposure.
No takes yet. Share an insight, caveat, or question.
Koning et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: